Cetirizine allergy pills recalled for potential ranitidine contamination
Rising Pharma Holdings is recalling four lots of 5 mg cetirizine hydrochloride tablets manufactured by Unique Pharmaceutical Laboratories due to possible cross-contamination with ranitidine, which could cause serious reactions including anaphylaxis for sensitive individuals. The nationwide recall involves 100-count bottles with lot numbers GY825029–GY825032 and expiration dates of 10/2028. Consumers should stop using affected bottles, check their bottle details, and contact Rising Pharma for guidance; affected patients or physicians can report adverse events to the FDA MedWatch program.